However, validation of these findings in tissues from COAD patients using the RT–qPCR showed that IFITM3, but not IFITM1, was highly expressed in the tumor (Fig. 1b and Supplementary Fig. 1c), which indicated the positive association of IFITM3 expression with the disease progression. Here, IFITM3 is linked to colon adenocarcinoma.